Recombinant vaccines are produced using recombinant DNA technology, with the help of a vector. These vaccines stimulate the immune system of an individual and provide immunity against various lethal disease.
These vaccines are safe and have less or no side-effects as compared to conventional vaccines, in the prevention of various diseases such as influenza, cholera, typhoid, and dengue.
Recombinant vaccines are also used in animals for prevention of diseases such as foot and mouth disease, pneumonia and septicemia, and pox disease. Vaccination results in the prevention of disease, by producing antibodies against the protein antigen of pathogenic microorganisms.
This report aims to provide a comprehensive presentation of the global market for Recombinant Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Vaccines. This report contains market size and forecasts of Recombinant Vaccines in global, including the following market information:
Global Recombinant Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Recombinant Vaccines Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Recombinant Vaccines companies in 2022 (%)
The global Recombinant Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
There is increase in the demand for livestock products, which in turn has increased growth of the animal recombinant vaccine segment and Europe dominates the animal recombinant vaccines market as compared to other regions due to highly organized livestock and huge demand of livestock product for the European population.
We surveyed the Recombinant Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Recombinant Vaccines Market Segment Percentages, by Type, 2022 (%)
Subunit Recombinant Vaccines
Attenuated Recombinant Vaccines
Vector Recombinant Vaccines
Global Recombinant Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Recombinant Vaccines Market Segment Percentages, by Application, 2022 (%)
Recombinant Human Vaccines
Animal Recombinant Vaccines
Global Recombinant Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Recombinant Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Recombinant Vaccines revenues share in global market, 2022 (%)
Key companies Recombinant Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Recombinant Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck & Co., Inc
Green Cross Corporation
Pfizer Inc.
Bayer AG
Sanofi S A.
Protein Science Corporation
GlaxoSmithKline Plc.
Novartis AG
Bharat Biotech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Recombinant Vaccines, market overview.
Chapter 2: Global Recombinant Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Recombinant Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Recombinant Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Recombinant Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Recombinant Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Vaccines Overall Market Size
2.1 Global Recombinant Vaccines Market Size: 2022 VS 2029
2.2 Global Recombinant Vaccines Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Recombinant Vaccines Sales: 2018-2029
3 Company Landscape
3.1 Top Recombinant Vaccines Players in Global Market
3.2 Top Global Recombinant Vaccines Companies Ranked by Revenue
3.3 Global Recombinant Vaccines Revenue by Companies
3.4 Global Recombinant Vaccines Sales by Companies
3.5 Global Recombinant Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Recombinant Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Recombinant Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Recombinant Vaccines Market Size Markets, 2022 & 2029
4.1.2 Subunit Recombinant Vaccines
4.1.3 Attenuated Recombinant Vaccines
4.1.4 Vector Recombinant Vaccines
4.2 By Type - Global Recombinant Vaccines Revenue & Forecasts
4.2.1 By Type - Global Recombinant Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Recombinant Vaccines Revenue, 2024-2029
4.2.3 By Type - Global Recombinant Vaccines Revenue Market Share, 2018-2029
4.3 By Type - Global Recombinant Vaccines Sales & Forecasts
4.3.1 By Type - Global Recombinant Vaccines Sales, 2018-2023
4.3.2 By Type - Global Recombinant Vaccines Sales, 2024-2029
4.3.3 By Type - Global Recombinant Vaccines Sales Market Share, 2018-2029
4.4 By Type - Global Recombinant Vaccines Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Recombinant Vaccines Market Size, 2022 & 2029
5.1.2 Recombinant Human Vaccines
5.1.3 Animal Recombinant Vaccines
5.2 By Application - Global Recombinant Vaccines Revenue & Forecasts
5.2.1 By Application - Global Recombinant Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Recombinant Vaccines Revenue, 2024-2029
5.2.3 By Application - Global Recombinant Vaccines Revenue Market Share, 2018-2029
5.3 By Application - Global Recombinant Vaccines Sales & Forecasts
5.3.1 By Application - Global Recombinant Vaccines Sales, 2018-2023
5.3.2 By Application - Global Recombinant Vaccines Sales, 2024-2029
5.3.3 By Application - Global Recombinant Vaccines Sales Market Share, 2018-2029
5.4 By Application - Global Recombinant Vaccines Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Recombinant Vaccines Market Size, 2022 & 2029
6.2 By Region - Global Recombinant Vaccines Revenue & Forecasts
6.2.1 By Region - Global Recombinant Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Recombinant Vaccines Revenue, 2024-2029
6.2.3 By Region - Global Recombinant Vaccines Revenue Market Share, 2018-2029
6.3 By Region - Global Recombinant Vaccines Sales & Forecasts
6.3.1 By Region - Global Recombinant Vaccines Sales, 2018-2023
6.3.2 By Region - Global Recombinant Vaccines Sales, 2024-2029
6.3.3 By Region - Global Recombinant Vaccines Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Recombinant Vaccines Revenue, 2018-2029
6.4.2 By Country - North America Recombinant Vaccines Sales, 2018-2029
6.4.3 US Recombinant Vaccines Market Size, 2018-2029
6.4.4 Canada Recombinant Vaccines Market Size, 2018-2029
6.4.5 Mexico Recombinant Vaccines Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Recombinant Vaccines Revenue, 2018-2029
6.5.2 By Country - Europe Recombinant Vaccines Sales, 2018-2029
6.5.3 Germany Recombinant Vaccines Market Size, 2018-2029
6.5.4 France Recombinant Vaccines Market Size, 2018-2029
6.5.5 U.K. Recombinant Vaccines Market Size, 2018-2029
6.5.6 Italy Recombinant Vaccines Market Size, 2018-2029
6.5.7 Russia Recombinant Vaccines Market Size, 2018-2029
6.5.8 Nordic Countries Recombinant Vaccines Market Size, 2018-2029
6.5.9 Benelux Recombinant Vaccines Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Recombinant Vaccines Revenue, 2018-2029
6.6.2 By Region - Asia Recombinant Vaccines Sales, 2018-2029
6.6.3 China Recombinant Vaccines Market Size, 2018-2029
6.6.4 Japan Recombinant Vaccines Market Size, 2018-2029
6.6.5 South Korea Recombinant Vaccines Market Size, 2018-2029
6.6.6 Southeast Asia Recombinant Vaccines Market Size, 2018-2029
6.6.7 India Recombinant Vaccines Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Recombinant Vaccines Revenue, 2018-2029
6.7.2 By Country - South America Recombinant Vaccines Sales, 2018-2029
6.7.3 Brazil Recombinant Vaccines Market Size, 2018-2029
6.7.4 Argentina Recombinant Vaccines Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Recombinant Vaccines Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Recombinant Vaccines Sales, 2018-2029
6.8.3 Turkey Recombinant Vaccines Market Size, 2018-2029
6.8.4 Israel Recombinant Vaccines Market Size, 2018-2029
6.8.5 Saudi Arabia Recombinant Vaccines Market Size, 2018-2029
6.8.6 UAE Recombinant Vaccines Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Merck & Co., Inc
7.1.1 Merck & Co., Inc Company Summary
7.1.2 Merck & Co., Inc Business Overview
7.1.3 Merck & Co., Inc Recombinant Vaccines Major Product Offerings
7.1.4 Merck & Co., Inc Recombinant Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 Merck & Co., Inc Key News & Latest Developments
7.2 Green Cross Corporation
7.2.1 Green Cross Corporation Company Summary
7.2.2 Green Cross Corporation Business Overview
7.2.3 Green Cross Corporation Recombinant Vaccines Major Product Offerings
7.2.4 Green Cross Corporation Recombinant Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 Green Cross Corporation Key News & Latest Developments
7.3 Pfizer Inc.
7.3.1 Pfizer Inc. Company Summary
7.3.2 Pfizer Inc. Business Overview
7.3.3 Pfizer Inc. Recombinant Vaccines Major Product Offerings
7.3.4 Pfizer Inc. Recombinant Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 Pfizer Inc. Key News & Latest Developments
7.4 Bayer AG
7.4.1 Bayer AG Company Summary
7.4.2 Bayer AG Business Overview
7.4.3 Bayer AG Recombinant Vaccines Major Product Offerings
7.4.4 Bayer AG Recombinant Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 Bayer AG Key News & Latest Developments
7.5 Sanofi S A.
7.5.1 Sanofi S A. Company Summary
7.5.2 Sanofi S A. Business Overview
7.5.3 Sanofi S A. Recombinant Vaccines Major Product Offerings
7.5.4 Sanofi S A. Recombinant Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 Sanofi S A. Key News & Latest Developments
7.6 Protein Science Corporation
7.6.1 Protein Science Corporation Company Summary
7.6.2 Protein Science Corporation Business Overview
7.6.3 Protein Science Corporation Recombinant Vaccines Major Product Offerings
7.6.4 Protein Science Corporation Recombinant Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 Protein Science Corporation Key News & Latest Developments
7.7 GlaxoSmithKline Plc.
7.7.1 GlaxoSmithKline Plc. Company Summary
7.7.2 GlaxoSmithKline Plc. Business Overview
7.7.3 GlaxoSmithKline Plc. Recombinant Vaccines Major Product Offerings
7.7.4 GlaxoSmithKline Plc. Recombinant Vaccines Sales and Revenue in Global (2018-2023)
7.7.5 GlaxoSmithKline Plc. Key News & Latest Developments
7.8 Novartis AG
7.8.1 Novartis AG Company Summary
7.8.2 Novartis AG Business Overview
7.8.3 Novartis AG Recombinant Vaccines Major Product Offerings
7.8.4 Novartis AG Recombinant Vaccines Sales and Revenue in Global (2018-2023)
7.8.5 Novartis AG Key News & Latest Developments
7.9 Bharat Biotech
7.9.1 Bharat Biotech Company Summary
7.9.2 Bharat Biotech Business Overview
7.9.3 Bharat Biotech Recombinant Vaccines Major Product Offerings
7.9.4 Bharat Biotech Recombinant Vaccines Sales and Revenue in Global (2018-2023)
7.9.5 Bharat Biotech Key News & Latest Developments
8 Global Recombinant Vaccines Production Capacity, Analysis
8.1 Global Recombinant Vaccines Production Capacity, 2018-2029
8.2 Recombinant Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Recombinant Vaccines Supply Chain Analysis
10.1 Recombinant Vaccines Industry Value Chain
10.2 Recombinant Vaccines Upstream Market
10.3 Recombinant Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Recombinant Vaccines in Global Market
Table 2. Top Recombinant Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Recombinant Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Recombinant Vaccines Revenue Share by Companies, 2018-2023
Table 5. Global Recombinant Vaccines Sales by Companies, (K Units), 2018-2023
Table 6. Global Recombinant Vaccines Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Recombinant Vaccines Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Recombinant Vaccines Product Type
Table 9. List of Global Tier 1 Recombinant Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Recombinant Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Recombinant Vaccines Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Recombinant Vaccines Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Recombinant Vaccines Sales (K Units), 2018-2023
Table 15. By Type - Global Recombinant Vaccines Sales (K Units), 2024-2029
Table 16. By Application ? Global Recombinant Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Recombinant Vaccines Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Recombinant Vaccines Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Recombinant Vaccines Sales (K Units), 2018-2023
Table 20. By Application - Global Recombinant Vaccines Sales (K Units), 2024-2029
Table 21. By Region ? Global Recombinant Vaccines Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Recombinant Vaccines Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Recombinant Vaccines Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Recombinant Vaccines Sales (K Units), 2018-2023
Table 25. By Region - Global Recombinant Vaccines Sales (K Units), 2024-2029
Table 26. By Country - North America Recombinant Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Recombinant Vaccines Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Recombinant Vaccines Sales, (K Units), 2018-2023
Table 29. By Country - North America Recombinant Vaccines Sales, (K Units), 2024-2029
Table 30. By Country - Europe Recombinant Vaccines Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Recombinant Vaccines Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Recombinant Vaccines Sales, (K Units), 2018-2023
Table 33. By Country - Europe Recombinant Vaccines Sales, (K Units), 2024-2029
Table 34. By Region - Asia Recombinant Vaccines Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Recombinant Vaccines Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Recombinant Vaccines Sales, (K Units), 2018-2023
Table 37. By Region - Asia Recombinant Vaccines Sales, (K Units), 2024-2029
Table 38. By Country - South America Recombinant Vaccines Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Recombinant Vaccines Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Recombinant Vaccines Sales, (K Units), 2018-2023
Table 41. By Country - South America Recombinant Vaccines Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Recombinant Vaccines Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Recombinant Vaccines Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Recombinant Vaccines Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Recombinant Vaccines Sales, (K Units), 2024-2029
Table 46. Merck & Co., Inc Company Summary
Table 47. Merck & Co., Inc Recombinant Vaccines Product Offerings
Table 48. Merck & Co., Inc Recombinant Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Merck & Co., Inc Key News & Latest Developments
Table 50. Green Cross Corporation Company Summary
Table 51. Green Cross Corporation Recombinant Vaccines Product Offerings
Table 52. Green Cross Corporation Recombinant Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Green Cross Corporation Key News & Latest Developments
Table 54. Pfizer Inc. Company Summary
Table 55. Pfizer Inc. Recombinant Vaccines Product Offerings
Table 56. Pfizer Inc. Recombinant Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Pfizer Inc. Key News & Latest Developments
Table 58. Bayer AG Company Summary
Table 59. Bayer AG Recombinant Vaccines Product Offerings
Table 60. Bayer AG Recombinant Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Bayer AG Key News & Latest Developments
Table 62. Sanofi S A. Company Summary
Table 63. Sanofi S A. Recombinant Vaccines Product Offerings
Table 64. Sanofi S A. Recombinant Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Sanofi S A. Key News & Latest Developments
Table 66. Protein Science Corporation Company Summary
Table 67. Protein Science Corporation Recombinant Vaccines Product Offerings
Table 68. Protein Science Corporation Recombinant Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Protein Science Corporation Key News & Latest Developments
Table 70. GlaxoSmithKline Plc. Company Summary
Table 71. GlaxoSmithKline Plc. Recombinant Vaccines Product Offerings
Table 72. GlaxoSmithKline Plc. Recombinant Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. GlaxoSmithKline Plc. Key News & Latest Developments
Table 74. Novartis AG Company Summary
Table 75. Novartis AG Recombinant Vaccines Product Offerings
Table 76. Novartis AG Recombinant Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Novartis AG Key News & Latest Developments
Table 78. Bharat Biotech Company Summary
Table 79. Bharat Biotech Recombinant Vaccines Product Offerings
Table 80. Bharat Biotech Recombinant Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Bharat Biotech Key News & Latest Developments
Table 82. Recombinant Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 83. Global Recombinant Vaccines Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global Recombinant Vaccines Production by Region, 2018-2023 (K Units)
Table 85. Global Recombinant Vaccines Production by Region, 2024-2029 (K Units)
Table 86. Recombinant Vaccines Market Opportunities & Trends in Global Market
Table 87. Recombinant Vaccines Market Drivers in Global Market
Table 88. Recombinant Vaccines Market Restraints in Global Market
Table 89. Recombinant Vaccines Raw Materials
Table 90. Recombinant Vaccines Raw Materials Suppliers in Global Market
Table 91. Typical Recombinant Vaccines Downstream
Table 92. Recombinant Vaccines Downstream Clients in Global Market
Table 93. Recombinant Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Recombinant Vaccines Segment by Type in 2022
Figure 2. Recombinant Vaccines Segment by Application in 2022
Figure 3. Global Recombinant Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Recombinant Vaccines Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Recombinant Vaccines Revenue, 2018-2029 (US$, Mn)
Figure 7. Recombinant Vaccines Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Recombinant Vaccines Revenue in 2022
Figure 9. By Type - Global Recombinant Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Recombinant Vaccines Revenue Market Share, 2018-2029
Figure 11. By Type - Global Recombinant Vaccines Sales Market Share, 2018-2029
Figure 12. By Type - Global Recombinant Vaccines Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Recombinant Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Recombinant Vaccines Revenue Market Share, 2018-2029
Figure 15. By Application - Global Recombinant Vaccines Sales Market Share, 2018-2029
Figure 16. By Application - Global Recombinant Vaccines Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Recombinant Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Recombinant Vaccines Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Recombinant Vaccines Revenue Market Share, 2018-2029
Figure 20. By Region - Global Recombinant Vaccines Sales Market Share, 2018-2029
Figure 21. By Country - North America Recombinant Vaccines Revenue Market Share, 2018-2029
Figure 22. By Country - North America Recombinant Vaccines Sales Market Share, 2018-2029
Figure 23. US Recombinant Vaccines Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Recombinant Vaccines Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Recombinant Vaccines Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Recombinant Vaccines Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Recombinant Vaccines Sales Market Share, 2018-2029
Figure 28. Germany Recombinant Vaccines Revenue, (US$, Mn), 2018-2029
Figure 29. France Recombinant Vaccines Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Recombinant Vaccines Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Recombinant Vaccines Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Recombinant Vaccines Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Recombinant Vaccines Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Recombinant Vaccines Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Recombinant Vaccines Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Recombinant Vaccines Sales Market Share, 2018-2029
Figure 37. China Recombinant Vaccines Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Recombinant Vaccines Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Recombinant Vaccines Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Recombinant Vaccines Revenue, (US$, Mn), 2018-2029
Figure 41. India Recombinant Vaccines Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Recombinant Vaccines Revenue Market Share, 2018-2029
Figure 43. By Country - South America Recombinant Vaccines Sales Market Share, 2018-2029
Figure 44. Brazil Recombinant Vaccines Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Recombinant Vaccines Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Recombinant Vaccines Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Recombinant Vaccines Sales Market Share, 2018-2029
Figure 48. Turkey Recombinant Vaccines Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Recombinant Vaccines Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Recombinant Vaccines Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Recombinant Vaccines Revenue, (US$, Mn), 2018-2029
Figure 52. Global Recombinant Vaccines Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Recombinant Vaccines by Region, 2022 VS 2029
Figure 54. Recombinant Vaccines Industry Value Chain
Figure 55. Marketing Channels
